Immunopathology of highly virulent pathogens: insights from Ebola virus

被引:101
作者
Zampieri, Carisa A. [1 ]
Sullivan, Nancy J. [1 ]
Nabel, Gary J. [1 ]
机构
[1] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1038/ni1519
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Ebola virus is a highly virulent pathogen capable of inducing a frequently lethal hemorrhagic fever syndrome. Accumulating evidence indicates that the virus actively subverts both innate and adaptive immune responses and triggers harmful inflammatory responses as it inflicts direct tissue damage. The host immune system is ultimately overwhelmed by a combination of inflammatory factors and virus-induced cell damage, particularly in the liver and vasculature, often leading to death from septic shock. We summarize the mechanisms of immune dysregulation and virus-mediated cell damage in Ebola virus-infected patients. Future approaches to prevention and treatment of infection will be guided by answers to unresolved questions about interspecies transmission, molecular mechanisms of pathogenesis, and protective adaptive and innate immune responses to Ebola virus.
引用
收藏
页码:1159 / 1164
页数:6
相关论文
共 67 条
  • [1] Protective immunity and susceptibility to infectious diseases: lessons from the 1918 influenza pandemic
    Ahmed, Rafi
    Oldstone, Michael B. A.
    Palese, Peter
    [J]. NATURE IMMUNOLOGY, 2007, 8 (11) : 1188 - 1193
  • [2] Ebola virus glycoprotein GP is not cytotoxic when expressed constitutively at a moderate level
    Alazard-Dany, N
    Volchkova, V
    Reynard, O
    Carbonnelle, C
    Dolnik, O
    Ottmann, M
    Khromykh, A
    Volchkov, VE
    [J]. JOURNAL OF GENERAL VIROLOGY, 2006, 87 : 1247 - 1257
  • [3] Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients
    Baize, S
    Leroy, EM
    Georges-Courbot, MC
    Capron, M
    Lansoud-Soukate, J
    Debré, P
    Fisher-Hoch, SP
    McCormick, JB
    McCormick, JB
    Georges, AJ
    [J]. NATURE MEDICINE, 1999, 5 (04) : 423 - 426
  • [4] Inflammatory responses in Ebola virus-infected patients
    Baize, S
    Leroy, EM
    Georges, AJ
    Georges-Courbot, MC
    Capron, M
    Bedjabaga, I
    Lansoud-Soukate, J
    Mavoungou, E
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2002, 128 (01) : 163 - 168
  • [5] Release of cellular proteases into the acidic extracellular milieu exacerbates Ebola virus-induced cell damage
    Barrientos, Laura G.
    Rollin, Pierre E.
    [J]. VIROLOGY, 2007, 358 (01) : 1 - 9
  • [6] The Ebola virus VP35 protein inhibits activation of interferon regulatory factor 3
    Basler, CF
    Mikulasova, A
    Martinez-Sobrido, L
    Paragas, J
    Mühlberger, E
    Bray, M
    Klenk, HD
    Palese, P
    García-Sastre, A
    [J]. JOURNAL OF VIROLOGY, 2003, 77 (14) : 7945 - 7956
  • [7] Ebola and Marburg virus-like particles activate human myeloid dendritic cells
    Bosio, CM
    Moore, BD
    Warfield, KL
    Ruthel, G
    Mohamadzadeh, M
    Aman, MJ
    Bavari, S
    [J]. VIROLOGY, 2004, 326 (02) : 280 - 287
  • [8] Ebola and Marburg viruses replicate in monocyte-derived dendritic cells without inducing the production of cytokines and full maturation
    Bosio, CM
    Aman, MJ
    Grogan, C
    Hogan, R
    Ruthel, G
    Negley, D
    Mohamadzadeh, M
    Bavari, S
    Schmaljohn, A
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2003, 188 (11) : 1630 - 1638
  • [9] BOWEN ETW, 1977, LANCET, V1, P571
  • [10] Ebola virus: The role of macrophages and dendritic cells in the pathogenesis of Ebola hemorrhagic fever
    Bray, M
    Geisbert, TW
    [J]. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2005, 37 (08) : 1560 - 1566